Prognostic factors for treated canine malignant lymphoma

Area of Science:

• Veterinary Oncology
• Canine Cancer Research
• Tumor Biology

Background:

• Canine malignant lymphoma is a common cancer requiring effective prognostic indicators.
• Chemotherapy response and survival times in dogs with lymphoma vary significantly.
• Identifying reliable prognostic factors is crucial for tailoring treatment strategies.

Purpose of the Study:

• To evaluate the prognostic significance of clinical, immunohistologic, and proliferation markers in dogs with malignant lymphoma.
• To determine the utility of argyrophil nucleolar organizer regions (AgNORs) as a prognostic tool.
• To correlate specific AgNOR characteristics with treatment outcomes and survival in canine lymphoma patients.

Main Methods:

• Biopsies from 74 dogs with malignant lymphoma were analyzed before chemotherapy.
• Evaluated parameters included histomorphology, immunophenotype (CD3, CD79a), and proliferation markers (Ki-67, PCNA, mitotic index, AgNORs).
• AgNORs were assessed qualitatively and quantitatively using image analysis on formalin-fixed, paraffin-embedded tissues.

Main Results:

• AgNORs demonstrated significant prognostic value in both univariate and multivariate survival analyses.
• Multivariate analysis revealed that B-cell type, larger mean and total AgNOR areas, shorter inter-AgNOR distance, and smaller AgNOR area to nucleus ratio correlated with longer survival.
• Specific AgNOR counts and area measurements predicted disease-free survival.

Conclusions:

• Argyrophil nucleolar organizer regions (AgNORs) are a valuable addition to prognostic assessment in canine malignant lymphoma.
• Quantitative AgNOR analysis provides crucial insights into predicting treatment outcomes and survival.
• This study highlights the benefit of incorporating AgNORs into the diagnostic workup for canine lymphoma.